Clinical trials use 8 to 12 weeks as the measurement endpoint for skin improvements, and that aligns with what most researchers report from injectable protocols
of Health and other interested parties are engaging with pharmaceutical companies and suggesting that they may want to investigate the possibility of developing a 1mg or 2mg tablet of B12 that could be prescribed by doctors to treat Pernicious Anaemia
The IV protocol can change based on the situation
What is missing: in-person evaluation, comprehensive lab work, hands-on injection training
Biologic drugs target specific immune pathways, but patients may still suffer opportunistic infections and longterm risks like cancer
Impact on Laboratory Test Results When individuals receive methylcobalamin injections, changes in laboratory test outcomes such as serum B12 levels and homocysteine measurements may occur, which can impact the understanding of test results and possibly result in misdiagnosis or improper treatment adjustments by healthcare professionals analyzing lab work of patients undergoing methylcobalamin therapy